Instalab

Malic Acid

Urine Test
Get an exploratory read on how well your cells are turning food into energy, beyond what routine labs can show.

Should you take a Malic Acid test?

This test is most useful if any of these apply to you.

Taking an SGLT2 Inhibitor for Diabetes
If you are on dapagliflozin or a similar drug, this test can show how the medication is shifting your cellular energy metabolism.
Curious About Cellular Energy
If you want an exploratory window into how well your cells are running the citric acid cycle, this is one piece of that picture.
Family History of Metabolic Disorders
If inherited metabolic conditions run in your family, this panel can flag patterns worth investigating further with a specialist.
Healthy but Want to Stay Ahead
If your standard labs look fine but you want to track deeper biology over time, this gives you a baseline you can revisit.

About Malic Acid

Most of what shows up in your urine is waste your body wants to get rid of. A small fraction is something more interesting: leftover signals from the chemistry happening deep inside your cells. Malic acid is one of those signals. It is a normal step in the chain of reactions your cells use to convert food into usable energy, and the amount that ends up in your urine can shift when that process is running unevenly.

This test is most commonly used as part of a broader organic acids panel, often ordered to investigate rare inherited metabolic conditions. For an adult who is mostly healthy and curious about cellular function, it is a research-grade window into a system that standard labs do not touch. Standardized clinical cutoffs do not yet exist, so a single number matters less than the pattern across the panel and the trajectory over time.

How Malic Acid Fits Into Your Energy Production

Inside nearly every cell, a circular series of chemical reactions (called the citric acid cycle) takes the breakdown products of carbohydrates, fats, and proteins and extracts the energy your body runs on. Malic acid is one of the molecules in that cycle. When the cycle is working smoothly, malic acid is consumed almost as quickly as it is made, so very little spills into the bloodstream and even less reaches the urine.

When the cycle is interrupted or overloaded, intermediates like malic acid can build up and be excreted. The test, run on a urine sample, reports the result corrected for urine concentration (in mmol per mol of creatinine, a small molecule used as a reference point for how dilute or concentrated the urine is). Reading any individual organic acid in isolation is risky. The interpretive power comes from seeing it alongside the other intermediates in the same pathway.

Inherited Metabolic Conditions

The clearest human evidence linking urinary malic acid to a specific disease comes from a condition called citrin deficiency, an inherited disorder affecting how the liver handles amino acids and energy substrates. In a study that included citrin deficiency patients and healthy controls, urinary malic acid was significantly elevated in patients and was one of several organic acids that contributed to a diagnostic model with strong accuracy.

Citrin deficiency is most often picked up in infants and young children, not adults, so this finding does not mean a slightly elevated malic acid in your urine signals that condition. It does illustrate the broader principle behind the test: when something is off in the way the body handles amino acids and the citric acid cycle, malic acid is one of the metabolites that tends to move.

Diabetes Medication and the Citric Acid Cycle

A randomized trial in adults with type 2 diabetes found that dapagliflozin, a medication in the SGLT2 inhibitor class (drugs that lower blood sugar by causing the kidneys to excrete more glucose), changed the pattern of citric acid cycle metabolites in 24-hour urine. While excretion of several intermediates rose, urinary malic acid excretion decreased.

The authors framed this as part of the medication's broader effect on kidney metabolism, not a sign of harm. The takeaway for someone tracking this marker is practical: if you start, stop, or change dose of an SGLT2 inhibitor between tests, expect your urinary malic acid to move, and interpret any change in that context rather than as a standalone signal.

Why One Reading Is Not Enough

Urinary metabolites are variable from day to day. In a study tracking urinary diet-related metabolites over multiple years, the within-person reproducibility (a statistical measure called the intraclass correlation coefficient) was modest for many markers, meaning a single urine sample captures only a slice of someone's habitual pattern. The same analysis suggested multiple samples per person may be needed to characterize habitual levels, depending on how variable the specific marker is.

No study has measured the day-to-day variability of urinary malic acid specifically. But the general pattern is clear: treat a single number as a snapshot, not a verdict. A practical approach is to get a baseline, retest in 3 to 6 months if you are making meaningful diet, supplement, or medication changes, and then at least annually to track your trajectory. Two readings months apart, taken under similar conditions, tell you far more than any single result ever can.

When Results Can Be Misleading

  • Hydration and urine concentration: very concentrated or very dilute urine can shift the raw numbers. Results corrected for creatinine help, but extreme cases still distort the picture.
  • Recent diet: organic acids in urine reflect, in part, what you have eaten and drunk in the past day. Country of residence alone explained a small but measurable share of variation in urinary metabolite levels in one large European study, likely capturing diet and environment together.
  • SGLT2 inhibitors: dapagliflozin and similar medications can lower urinary malic acid excretion as part of their effect on kidney metabolism, not because anything is wrong with your cells.
  • Acute illness or short-term stress: the citric acid cycle is sensitive to fever, infection, intense fasting, and similar stressors. A single urine collected during or right after one of these events may not reflect your usual pattern.

What to Do With an Out-of-Pattern Result

Because this is a research-grade marker without standardized cutoffs, a single elevated or depressed reading should trigger investigation rather than alarm. The most useful next steps are usually to look at the rest of the organic acids on the same panel (especially citric acid, fumaric acid, succinic acid, and other citric acid cycle intermediates), and to confirm with a repeat collection a few weeks later under similar conditions.

If the pattern persists, the picture becomes more meaningful when paired with markers of kidney function (creatinine, cystatin C, eGFR), blood sugar control (glucose, HbA1c), and basic mitochondrial cofactors (magnesium, B vitamins). A clinician with experience in metabolic medicine or biochemical genetics is the right person to interpret a sustained shift, especially if multiple intermediates in the same pathway are moving together.

What Moves This Biomarker

Evidence-backed interventions that affect your Malic Acid level

Decrease
Take dapagliflozin (an SGLT2 inhibitor) for type 2 diabetes
If you start or are taking an SGLT2 inhibitor like dapagliflozin, expect your urinary malic acid to drop. A randomized trial in adults with type 2 diabetes found that dapagliflozin changed the pattern of citric acid cycle metabolites in 24-hour urine, with malic acid excretion specifically decreasing while several other intermediates rose. The change appears to reflect the drug's effect on kidney metabolism rather than disease in your cells, so the lower reading is not itself harmful, but it means you cannot compare a pre-medication baseline directly to an on-medication number.
MedicationModerate Evidence

Frequently Asked Questions

References

5 studies
  1. Wang P, Chen P, Yang X, Cen Z, Zhang Y, He Q, Wu B, Huang XClinical and Translational Medicine2025
  2. Pezzica S, Pratesi F, Sabatini S, Carli F, Mengozzi a, Solini a, Gastaldelli aCardiovascular Diabetology2025
  3. Goerdten J, Rattner J, Merdas M, Achaintre D, Yuan L, Russo P, Veidebaum T, Molnar D, Lissner L, De Henauw S, Moreno LA, Aleksandrova K, Foraita R, Nothlings U, Keski-rahkonen P, Floegel aThe Journal of Nutrition2025